Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, Marinucci LN, Blight AR, Fampridine MS-F203 Investigators Lancet. 2009 Feb 28; 373(9665):732-8. PMID: 19249634. Abstract CommentRecommendBookmarkWatch